Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #26385 on CuraScientific Corp (CSTF)
SamTheTrader
03/12/21 11:45 AM
#26401 RE: zigzagman #26385
One of the key elements driving the rapid adoption of DiOx+ in the medical industry is its effectiveness in eliminating dangerous pathogens and viruses. BNOW is on track to complete its Form-10 Filing and Audit to go SEC Fully Reporting this month, which will coincide with up-listing to the OTCQB. https://finance.yahoo.com/news/boon-industries-continues-expand-distribution-130000994.html